Scale | Baseline score | Follow up score | Mean differenced (N = 41) | SD | 95% CI | Significancee | ||
---|---|---|---|---|---|---|---|---|
Mean (N = 51) | SD | Mean (N = 41)c | SD | |||||
Global health status/QOL | 49.8 | 22.0 | 43.9 | 30.4 | −8.33 | 30.0 | −18.0, 1.1 | t = 1.8; df = 40 p = 0.08 |
Physical functioning | 53.07 | 28.8 | 34.31 | 24.5 | −20.81 | 29.2 | −30.03, −11.59 | t = 4.56; df = 40 p < 0.001 |
Role functioning | 42.16 | 34.5 | 21.54 | 26.2 | −22.76 | 37.8 | −34.69, −10.84 | t = 3.86; df = 40; p < 0.001 |
Emotional functioning | 53.43 | 26.4 | 42.07 | 31.2 | −14.03 | 32.8 | −24.38, −3.69 | t = − 2.74; df = 40 p = 0.009 |
Cognitive functioning | 75.49 | 23.4 | 71.54 | 26.9 | −6.1 | 26.0 | −14.31, + 2.12 | t = 1.5; df = 40 p = 0.141 |
Social functioning | 57.19 | 23.2 | 37.4 | 26.8 | −23.17 | 27.9 | −31.96, −14.38 | t = 5.33; df = 40 p < 0.001 |
Family supporta | 82.57 | 20.4 | 80.49 | 14.4 | −6.5 | 12.9 | − 10.58, − 2.43 | t = 3.23; df = 40 p = 0.002 |
Fatigue | 52.07 | 28.9 | 71.27 | 28.8 | 20.87 | 35.2 | 9.78, 31.96 | t = 3.8; df = 40 p < 0.001 |
Nausea and vomiting | 40.2 | 34.4 | 54.07 | 37.6 | 13.0 | 39.0 | 0.7, 25.31 | t = 2.14; df = 40 p = 0.039 |
Pain | 45.42 | 32.7 | 71.54 | 28.7 | 27.64 | 37.6 | 15.78, 39.5 | t = 4.71; df = 40 p < 0.001 |
Dyspnoea | 24.18 | 26.7 | 27.64 | 29.7 | 5.69 | 30.6 | −4.0, 15.36 | t = 1.19; df = 40; p = 0.241 |
Insomnia | 33.33 | 32.0 | 43.9 | 35.3 | 13.82 | 36.5 | 2.3, 25.34 | t = 2.43; df = 40 p = 0.02 |
Loss of appetite | 42.48 | 34.0 | 54.47 | 37.8 | 13.0 | 40.1 | 0.37, 25.65 | t = 2.08; df = 40 p = 0.044 |
Constipation | 30.06 | 35.4 | 47.97 | 41.5 | 16.26 | 34.3 | 5.45, 27.07 | t = 3.04; df = 40 p = 0.004 |
Diarrhoea | 10.46 | 18.2 | 4.88 | 14.1 | −5.69 | 21.0 | −12.3, 0.92 | t = 1.74; df = 40 p = 0.09 |
Financial difficultiesb | 50.98 | 31.5 | 77.24 | 21.6 | 30.89 | 32.8 | 20.53, 41.25 | t = 6.03; df = 40 p < 0.001 |